Wall Street brokerages forecast that Acadia Healthcare Company, Inc. (NASDAQ:ACHC) will announce sales of $729.80 million for the current fiscal quarter, according to Zacks. Seven analysts have issued estimates for Acadia Healthcare’s earnings. The highest sales estimate is $738.60 million and the lowest is $721.50 million. Acadia Healthcare reported sales of $734.67 million during the same quarter last year, which would suggest a negative year-over-year growth rate of 0.7%. The company is scheduled to report its next quarterly earnings results on Tuesday, November 7th.

On average, analysts expect that Acadia Healthcare will report full-year sales of $729.80 million for the current financial year, with estimates ranging from $2.84 billion to $2.89 billion. For the next year, analysts anticipate that the firm will post sales of $3.09 billion per share, with estimates ranging from $3.04 billion to $3.12 billion. Zacks’ sales calculations are an average based on a survey of research firms that follow Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. The company had revenue of $715.90 million for the quarter, compared to analysts’ expectations of $717.38 million. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The business’s revenue for the quarter was down 5.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.73 earnings per share.

Several analysts have recently weighed in on ACHC shares. Mizuho raised their price objective on shares of Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a report on Friday, July 28th. BidaskClub raised Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Saturday, June 10th. Craig Hallum restated a “buy” rating and set a $65.00 price target (up from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Zacks Investment Research lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday. Finally, UBS AG reaffirmed a “positive” rating and set a $60.00 price target (up from $54.00) on shares of Acadia Healthcare in a report on Monday, July 31st. Two research analysts have rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. Acadia Healthcare presently has a consensus rating of “Buy” and an average price target of $56.55.

TRADEMARK VIOLATION NOTICE: This news story was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/04/zacks-brokerages-anticipate-acadia-healthcare-company-inc-achc-will-announce-quarterly-sales-of-729-80-million.html.

In related news, President Brent Turner sold 206,252 shares of the company’s stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $10,454,913.88. Following the completion of the sale, the president now owns 81,106 shares in the company, valued at $4,111,263.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Christopher L. Howard sold 53,713 shares of the company’s stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $2,722,711.97. Following the completion of the sale, the executive vice president now owns 147,286 shares of the company’s stock, valued at approximately $7,465,927.34. The disclosure for this sale can be found here. Insiders sold a total of 3,085,693 shares of company stock worth $157,729,099 in the last ninety days. Insiders own 11.10% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in the business. BlackRock Inc. boosted its holdings in Acadia Healthcare by 65.6% during the second quarter. BlackRock Inc. now owns 8,523,077 shares of the company’s stock worth $420,871,000 after buying an additional 3,377,291 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Acadia Healthcare by 8.9% in the 2nd quarter. Vanguard Group Inc. now owns 6,254,532 shares of the company’s stock valued at $308,849,000 after acquiring an additional 511,299 shares during the last quarter. Aristotle Capital Management LLC bought a new stake in shares of Acadia Healthcare in the 1st quarter valued at about $140,071,000. FMR LLC increased its stake in shares of Acadia Healthcare by 26.4% in the 2nd quarter. FMR LLC now owns 2,775,451 shares of the company’s stock valued at $137,052,000 after acquiring an additional 580,449 shares during the last quarter. Finally, Frontier Capital Management Co. LLC increased its stake in shares of Acadia Healthcare by 11.5% in the 2nd quarter. Frontier Capital Management Co. LLC now owns 2,328,063 shares of the company’s stock valued at $114,960,000 after acquiring an additional 240,975 shares during the last quarter.

Acadia Healthcare (NASDAQ:ACHC) opened at 47.50 on Wednesday. Acadia Healthcare has a 12 month low of $32.54 and a 12 month high of $54.34. The stock’s 50 day moving average price is $46.99 and its 200 day moving average price is $46.21. The firm has a market capitalization of $4.17 billion, a P/E ratio of 521.98 and a beta of 1.07.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.